Holen Sie sich die Stockscreener-App
79.09
0.40%
-0.32
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus - ts2.tech
Precision Trading with Disc Medicine Inc. (IRON) Risk Zones - Stock Traders Daily
Disc Medicine Earnings Notes - Trefis
Analysts Conflicted on These Healthcare Names: Moderna (MRNA), Disc Medicine (IRON) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Moderna (MRNA) and Disc Medicine (IRON) - The Globe and Mail
Analysts Have Conflicting Sentiments on These Healthcare Companies: AbbVie (ABBV), Disc Medicine (IRON) and BioMarin Pharmaceutical (BMRN) - The Globe and Mail
Disc Shares Slip Amid Report FDA’s Prasad is Skeptical of Bitopertin’s Efficacy - BioSpace
Avoiding Lag: Real-Time Signals in (IRON) Movement - news.stocktradersdaily.com
Breakouts Watch: Is Disc Medicine Inc. stock attractive for hedge fundsRisk Management & Free Growth Oriented Trading Recommendations - Улправда
Disc Medicine (NASDAQ: IRON) Stock Drops on FDA Voucher Speculation: Latest News, Analyst Forecasts, and What Investors Watch Next - ts2.tech
Breakout Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatRisk Management & Technical Confirmation Trade Alerts - Улправда
Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Can Disc Medicine Inc. stock deliver consistent earnings growthJuly 2025 Levels & Risk Controlled Swing Trade Alerts - Улправда
Stifel reaffirms Buy rating on Disc Medicine stock amid FDA review speculation - Investing.com Canada
Jefferies reiterates Buy rating on Disc Medicine stock amid FDA concerns - Investing.com Canada
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’ - Asianet Newsable
Disc Medicine (IRON) Gains Confidence Despite Timeline Concerns - GuruFocus
Disc Medicine stock rating reiterated at Outperform by BMO amid FDA review - Investing.com
Disc Medicine (IRON) Maintains Positive Outlook Amid CNPV Skepti - GuruFocus
Disc Medicine drops on report of FDA skepticism over rare blood disorder drug - TradingView — Track All Markets
Disc Medicine (NASDAQ: IRON) Stock Tumbles on Insider-Selling Headlines as Bitopertin FDA Decision Nears — News, Analyst Forecasts, and What to Watch (Dec. 19, 2025) - ts2.tech
Disc Medicine Enters Oversold Territory (IRON) - Nasdaq
Disc Medicine (IRON) Shares Decline Over 14% - GuruFocus
FDA Fast-Track Review Challenges Impact Disc Medicine's (IRON) B - GuruFocus
Disc Medicine (NASDAQ:IRON) Shares Down 9% After Insider Selling - MarketBeat
How supply chain issues affect Disc Medicine Inc. stockBond Market & Real-Time Volume Spike Alerts - DonanımHaber
Is Disc Medicine Inc. stock a buy before product launchesRate Hike & Expert Approved Momentum Trade Ideas - DonanımHaber
Aug Movers: Why Disc Medicine Inc stock is seen as undervalued2025 Earnings Impact & Capital Efficient Trading Techniques - moha.gov.vn
Why Disc Medicine Inc. stock is seen as undervaluedJuly 2025 Momentum & Reliable Entry Point Alerts - Улправда
Downgrade Watch: Can Disc Medicine Inc. stock deliver surprise earnings beatJuly 2025 Recap & Daily Profit Focused Screening - Улправда
Disc Medicine (NASDAQ:IRON) Director Sells $68,968.38 in Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Short Covering: How analysts rate Disc Medicine Inc. stock todayFed Meeting & Weekly Setup with ROI Potential - Улправда
Hedge Fund Moves: Is Disc Medicine Inc. stock recession proofProduct Launch & Entry Point Confirmation Signals - Улправда
Is Disc Medicine Inc. stock attractive for hedge fundsChart Signals & Precise Swing Trade Entry Alerts - Bollywood Helpline
Disc Medicine Insider Sold Shares Worth $16,858,639, According to a Recent SEC Filing - marketscreener.com
Disc Medicine Insider Sold Shares Worth $1,194,372, According to a Recent SEC Filing - marketscreener.com
Kevin Bitterman Sells 62,693 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine (NASDAQ:IRON) Insider William Jacob Savage Sells 13,093 Shares - MarketBeat
Insider Sell: William Savage Sells 13,093 Shares of Disc Medicine Inc (IRON) - GuruFocus
IRON Receives Updated Overweight Rating and Raised Price Target from Wells Fargo | IRON Stock News - GuruFocus
Disc Medicine (NASDAQ:IRON) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
John Quisel Sells 40,000 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine Insider Sold Shares Worth $3,721,931, According to a Recent SEC Filing - marketscreener.com
Frazier Life Sciences Management L.P. Has $87.64 Million Holdings in Disc Medicine, Inc. $IRON - MarketBeat
This is why Disc Medicine, Inc. (IRON) is a buy on Wall Street - MSN
All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - MSN
Eventide Asset Management LLC Buys 126,212 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. $IRON Position Lowered by Bain Capital Life Sciences Investors LLC - MarketBeat
Has Disc Medicine’s 2025 Surge Already Gone Too Far After Pipeline Progress Fuels Rally? - Yahoo Finance
Leering Partners Lifts Disc Medicine, Inc. (IRON) Following EPP Drug NDA Application - MSN
Jefferies Keeps Their Buy Rating on Disc Medicine (IRON) - The Globe and Mail
Discipline and Rules-Based Execution in IRON Response - news.stocktradersdaily.com
Disc Medicine (IRON): Reassessing Valuation After Encouraging RALLY-MF Phase 2 Anemia Data - simplywall.st
H.C. Wainwright reiterates Buy rating on Disc Medicine stock By Investing.com - Investing.com Canada
This is Why Disc Medicine, Inc. (IRON) is a Buy on Wall Street - Finviz
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):